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Background: Carotid-femoral pulse wave velocity (PWV) is
an important measure of arterial stiffness, which is an
independent predictor of cardiovascular morbidity and
mortality. In this study, we used an integrated genetic,
epigenetic and transcriptomics approach to uncover novel
molecular mechanisms contributing to PWV.
Methods and results: We measured PWV in 1505
healthy twins of European descendent. A genomewide
association analysis was performed using standardized
residual of the inverse of PWV. We identified one single-
nucleotide polymorphism (rs7164338) in the calcium and
integrin-binding protein-2 (CIB2) gene on chromosome
15q25.1 associated with PWV [b¼0.359, standard error
(SE)¼0.07, P¼4.8 10–8]. The same variant was also
associated with increased CIB2 expression in leucocytes
(b¼ 0.034, SE¼0.008, P¼4.9510–5) and skin
(b¼ 0.072, SE¼0.01, P¼2.3510–9) and with
hypomethylation of the gene promoter (b¼0.899,
SE¼0.098, P¼3.6310–20).
Conclusion: Our data indicate that reduced methylation
of the CIB2 promoter in individuals carrying rs7164338
may lead to increased CIB2 expression. Given that CIB2 is
thought to regulate intracellular calcium levels, an increase
in protein levels may prevent the accumulation of serum
calcium and phosphate, ultimately slowing down the
process of vascular calcification. This study shows the
power of integrating multiple omics to discover novel
cardiovascular mechanisms.
Keywords: arterial stiffness, arteriosclerosis, association,
calcium and integrin-binding protein-2, pulse wave
velocity, vascular calcification
Abbreviations: CIB2, calcium and integrin-binding
protein-2; GTEx, genotype-tissue expression; GWA,
genomewide association; MuTHER, Multiple Tissue Human
Expression Resource; PWV, pulse wave velocity
INTRODUCTION
A
rterial stiffening represents a hallmark of vascular
ageing. Carotid-femoral pulse wave velocity (PWV)
is an important measure of central arterial stiffness
[1]. A growing body of evidence supports the association
between arterial stiffness and increased risk of developing
ageing-related conditions such as myocardial infarction [2],
hypertension [3], chronic kidney disease [4] and cognitive
dysfunction [5]. Furthermore, PWV can be used as inde-
pendent predictor of hypertension [6], coronary artery
disease and stroke [7] in healthy individuals. Finally, a
recent study suggests that molecular mechanisms related
to arterial stiffening and cardiovascular mortality are not
fully encompassed by the traditional cardiovascular risk
factors [8]. To date, the exact cause of age-related aortic
stiffening still remains unknown. Twin and family studies
estimated that PWV has a heritability of approximately 40%
[9–11]. Genomewide association (GWA) studies identified
two main loci associated with PWV: collagen type 4 (COL4-
A), which is the major structural component of basement
membranes [12], and the chromosome 14q32.2 locus that
harbours a gene enhancer for the B-cell chronic lympho-
cytic leukaemia/lymphoma 11B (BCL11B) gene [10].
Our group previously reported that aortic stiffening is
largely independent of classical risk factors for atheroscle-
rosis [9]. We also demonstrated that, despite calcification
often colocalizes with atherosclerotic plaque, arterial stiff-
ness is associated with aortic calcification rather than coex-
istent atheromatous plaque [13]. Moreover, we showed that
the link between PWV and calcification is mainly driven by
genetic factors (heritability¼ 0.77) [13].
In this article, we used a systems-based approach com-
bining genomics, transcriptomics and epigenomics, to
identify novel molecular mechanisms contributing to PWV.
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METHODS
Participants
The TwinsUK cohort (www.twinsuk.ac.uk, also referred
to as the UK Adult Twin Register) is an adult twin
British registry shown to be representative of the UK
female population [14,15]. From this registry, a total of
1505 individuals had PWV measurements and were
included in the analysis. The study was approved by the
Research Ethics Committee of St. Thomas’ Hospital,
London, UK, and all study participants provided informed
written consent.
Pulse wave velocity measurements
Vascular measurements were performed in a quiet
temperature-controlled (22–248C) vascular laboratory after
at least 10-min rest. Brachial blood pressure was measured
according to British Hypertension recommendations
using a validated automated oscillometric device (Omron,
705 IT; Omron Healthcare, Kyoto, Japan) [16]. PWV was
determined using the Sphygmocor system (Atcor, New
South Wales, Australia) by sequentially recording carotid
and femoral pressure waveforms using applanation ton-
ometry, referenced to the R-wave of the electrocardiogram
over a 10-s period. PWVwas calculated as from path length/
transit time. Transit time is measured using the intersecting
tangent method and path length taken as the distance
between the sternal notch and femoral artery at the point
of applanation. Coefficient of variation between consecu-
tive measures of PWV using the intersecting tangents
method is less than 7% [17].
Genotype
TwinsUK samples were typed with the Infinium 317K and
610K assay (Illumina, San Diego, California, USA; http://
www.illumina.com/) at two different centres, the Centre for
Inherited Diseases Research (USA) and the Wellcome Trust
Sanger Institute. We pooled the normalized intensity data
and called genotypes on the basis of the Illluminus algor-
ithm. No calls were assigned if the most likely call was less
than a posterior probability of 0.95. Validation of pooling
was done by visual inspection of 100 random, shared
single-nucleotide polymorphisms (SNPs) for overt batch
effects; none were observed. We excluded SNPs that had a
call rate less than 97% (for SNPs with MAF 5%) or less than
99% (for SNPs with 1%  MAF < 5%), Hardy–Weinberg
equilibrium P values less than 106 and minor allele fre-
quencies less than 1%. We also removed individuals in
whom the sample call rate was less than 98%; the hetero-
zygosity across all SNPs was  2 standard deviations from
the sample mean; there was evidence of non-European
ancestry as assessed by principal component analysis com-
parison with HapMap3 populations; and the observed
pairwise identity by descent probabilities suggested sample
identity errors. Imputation of genotypes was carried out
using the software IMPUTE V2 (https://mathgen.stats.ox.-
ac.uk/impute/impute_v2.html) [18]. Further quality con-
trols (call rate 90%, MAF 0.01, Hardy–Weinberg
equilibrium 10–4) were applied to the results post-
GWA analysis.
Genomewide association analysis
The GWA analysis was performed using standardized
residuals. Those were obtained for the inverse of PWV
adjusting for age, sex and BMI. As a result of the trans-
formation, PWV had a normal distribution (mean of 0 and
standard deviation of 1) across TwinsUK.
To account for family structure in the TwinsUK cohort,
we utilized the GenABEL software package (http://
www.genabel.org/) [19] which is designed for GWA
analysis of family-based data by incorporating a pairwise
kinship matrix calculated using genotyping data in the
polygenic model to correct relatedness and hidden popu-
lation stratification. The linear regression implemented in
the software was used to test the association between a
given SNP and PWV.
To validate our result, we obtained access to rs7164338
summary results generated by the AortaGen consortium as
part of their study [10]. The nine populations included in
AortaGen were of different origins with a 50 : 50 sex ratio
[10]. A description of the populations included in the
AortaGen study, as well as the statistical methods employed
in their meta-analysis, has been reported in detail in Mitch-
ell et al. [10].
The meta-analysis of TwinsUK and AortaGen results was
performed using Han and Eskin’s random-effect inverse
variance method as implemented in the software META-
SOFT (http://genetics.cs.ucla.edu/meta) [20]. The Han and
Eskin’s methods have been shown to provide more robust
results in the presence of heterogeneity [20]. In addition, to
test the presence and measure the amount of between-
study heterogeneity, we used two different metrics:
Cochran’s Q statistic [21] and I2 [22]. A P value less than
0.05 in Cochran’s Q test and I2 above 50% were considered
evidences of large heterogeneity.
Bioinformatic analysis
To query the publicly available data of the Encyclopedia of
DNA Elements (ENCODE) project [23], we used HaploReg
version 2 (http://www.broadinstitute.org/mammals/hap-
loreg/haploreg.php) [24] to search for SNPs with functional
annotations in high linkage disequilibrium (r2> 0.8) with
rs7164338 and RegulomeDB (http://regulomedb.org/) [25]
to rank potential functional roles for SNPs identified by
HaploReg. In the HaploReg analysis, we used the European
population included in Phase 1 of the 1000 genome project
for linkage disequilibrium calculation, the ENCODE data as
source for epigenomes and both Genomic Evolutionary
Rate Profiling (GERP) and SiPhy-omega algorithms to
analyse the conservation in mammals.
The scoring system for RegulomeDB ranges from 1 to 6
with the strongest evidence for functional roles as scores 1
(a–f). A score of 2 includes evidence of transcription factor-
binding and DNase footprint signals. Scores of 1 require
additional evidence of effects of the SNP on specific gene
expression.
Expression analysis
We used the genomewide expression data from the lym-
phoblastoid cell lines (LCLs) and from the skin samples
extracted from the Multiple Tissue Human Expression
Mangino et al.
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Resource (MuTHER) (www.muther.ac.uk) [26]. The project,
established by the Wellcome Trust in 2007, provides a
resource of genetic and genomic data from three tissues
(lymphocytes, skin biopsies and subcutaneous fat). Gene
expression was analysed with the Illumina Human HT-12
V3 chip [26]. The results generated by the project in the
different tissue are publically available (http://www.mu-
ther.ac.uk/Data.html). MUTHER expression analyses were
performed using GenABEL adjusting for the appropriate
covariate (age, family structure and tissue batch) [26]. For
this article, we extracted expression levels of calcium and
integrin-binding protein-2 (CIB2) in LCL and Skin and
rs7164338 from the online database. To validate our results
in a different dataset, we used the online tool Genevar
(V3.3.0) (https://www.sanger.ac.uk/resources/software/
genevar/) [27]. Genevar is a Java application designed for
the analysis and visualization of SNP–gene associations in
different expression quantitative trait loci (eQTL) studies.
We employed the option ‘cis-eQTL-SNP’ selecting the data
generated by Stranger et al. [28] as reference study and
testing a linear regression between the SNP and the gene
after 10 000 nonparametric permutations.
Finally, tissue-specific (artery aorta) SNP-expression
associations analysis was performed using data from the
genotype-tissue expression (GTEx) project online portal
(http://www.gtexportal.org) [29]. GTEx presents a compre-
hensive atlas of gene expression and regulation across
multiple human tissues. The online database provides easy
access to eQTLs, alternative splicing and the tissue speci-
ficity of gene regulatory mechanisms.
Methylation analysis
DNA methylation levels for 69 probes spanned in a region
500K across CIB2 locus were obtained using the Illumina
Infinium 450k chip array in 350 randomly selected indi-
viduals from the TwinsUK cohort. Similarly to the GWA
and expression analyses, we tested the association
between whole-blood DNA methylation patterns and
rs7164338 using GenABEL [19]. The analysis was per-
formed using residual of the methylation probes adjusted
for age, sex and known source of batch effect (methyl-
ation chip, sample position on methylation chip and
blood cell count).
To control for multiple testing, we calculated the effec-
tive number of tests from the correlation matrix for each
methylation probe (69 69) using the method of Gao et al.
[30]. After the pairwise correlation of the 69 analysed
probes, the threshold of statistical significance was esti-
mated at P less than 8.77 10–4.
The replication sample set included 172 individuals from
TwinsUK. These samples were not related/overlapping
with the discovery dataset. They were analysed using the
Illumina HumanMethylation27 DNA Analysis BeadChip
assay. As per the discovery, the validation analysis was
performed using GenABEL [19] to correct for family struc-
ture and zygosity on the residuals of the methylation probes
adjusted for age and sex, and know sources of batch effect
(methylation chip, sample position on methylation chip
and blood cell count). For the replication analysis, a P value
less than 0.05 was considered significant as only one probe
was tested.
Mendelian randomization
We reported that methylation levels in the promoter region
of CIB2 (probe cg20761322) were associated with expres-
sion levels of the gene in LCLs. However, this observation
cannot generally distinguish between association and cau-
sation [31]. In order to make causal inferences, we used a
method called Mendelian randomization. This technique
relies on the fact that genotypes are essentially random
assortment of alleles at the time of gamete production and
fertilization as indicated by Mendel’s Second Law [31].
Hence, using a genetic variant (rs7164338) enables us to
obtain unbiased estimates of the effects of a putative causal
variable (cg20761322) without conducting a traditional
randomized trial [32].
InMendelian randomization analysis, we included all the
samples (n¼ 221) that had data across three ‘omics’
(genetics, expression, methylation). We used the general-
ized method of moments with cluster-robust heteroskedas-
tic-consistent variance estimates [33]. Under, weak and
overidentification limitations were checked using ivreg2
command in Stata (version 14; StataCorp LP, College
Station, Texas, USA).
RESULTS
The detailed characteristics of the participants included in
this study are reported in Table 1. In brief, 1505 healthy
twins with PWV measures available were included in the
GWA analysis. They were of European descendent, mostly
females (99.2%), with an average age of 59 years (9 years).
Their mean PWV was 9.3m/s (1.9m/s) and their mean
pulse pressure was 53.6mmHg (13.3mmHg). The
majority of the participants included in the analysis
(80%) were not under antihypertensive medications.
We calculated that our study (n¼ 1505) had 80% power
to detect a variant (minor allele frequency 10%) which has
an effect on PWV of 0.73m/s at a statistical threshold of P
5 10–8 (Supplemental Figure 1, http://links.lww.com/
HJH/A521).
TABLE 1. Demographic characteristics of the study population
(n¼1505)
Variable
M:F 0.8%:99.2%
Age (years) 59.1 (9.4)a
BMI (kg/m2) 26.5 (4.9)a
PWV (m/s) 9.3 (1.9)a
DBP (mmHg) 75.5 (9.7)a
SBP (mmHg) 129.1 (19.3)a
PP (mmHg) 53.6 (13.3)a
Medication
B-blockers 89 (5.9%)
Diuretics 125 (8.3%)
Calcium-channel antagonists 78 (5.2%)
ACE inhibitors 99 (6.6%)
Angiotensin receptor inhibitors 54 (3.6%)
No medication 1200 (80%)
Not known 11 (0.7%)
ACE, angiotensin-converting enzyme; PP, pulse pressure; PWV, pulse wave velocity.
aMean (standard deviation).
Calcium and integrin-binding protein-2
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We performed a GWA to identify the genetic variations
accounting for the inherited component of PWV. The result
of the analysis is summarized in Fig. 1. The GWAS inflation
(lGC) was 1.011, indicating that there was no significant
population stratification or it was very minor. The quantile–
quantile plot shows very little digression from the expected
distribution under the null hypothesis (only present in the
extremely low P values) (Supplemental Figure 2, http://
links.lww.com/HJH/A521) confirming the absence of hid-
den relatedness and/or potential population stratification.
We, first, sought to replicate the two loci previously
reported on chromosomes 13q34 (rs3742207) [12] and
14q32.2 (rs7152623) [10]. The power calculations showed
that our sample size was not able to detect association
for these two loci (rs3742207: 61%; rs7152623: 28%) at
statistical significant level (P  0.01). Despite the associ-
ation results of the two SNPs that were indeed not statisti-
cally significant (rs3742207: b ¼ 0.08 0.07, P¼ 0.31;
rs7152623: b¼0.01 0.04, P¼ 0.7), we observed that
the effect sizes of the minor alleles were in the same
direction in both cases. Altogether these results suggest
that we may have replicated the previous findings but the
sample size of our dataset affected the power to detect
association for these two loci.
We identified 11 novel common variants associated with
PWV in the CIB2 gene on the long arm of chromosome 15
(15q25.1) (Fig. 2 and Table 2). The strongest association
with PWV was observed for the intronic marker rs7164338
with a genomewide statistical significant P value equal to
4.8 10–8. To perform a technical validation, we compared
rs7164338-imputed genotypes (rs7164338 had quality
imputation score¼ 0.966) with the direct genotypes
obtained from the next-generation sequence available for
49% of the samples included in the GWA. We observed
100% concordance between the next-generation sequence
and the imputed genotypes. This may suggest that the
association is not because of a technical artefact (i.e.
imputation miscall). Furthermore, we tried to validate
rs7164338 results in a different cohort. In particular, we
request access to rs7164338 summary results generated by
the AortaGen consortia [10]. Although this polymorphism
was not significant in the AortaGen meta-analysis
(P¼ 0.409) (Table 3), the effect of the minor allele (C)
was in the same direction (b¼0.010 0.012) (Table 3).
The meta-analysis between the two datasets showed a
suggestive P value of 5.87 10–5 (b¼0.177 0.174)
(Table 3). However, both I2 and Cochran’s Q metrics
detected a very high between-study heterogeneity
(I2¼ 95% and Cochran’s Q P¼ 1.83 10–6) reflecting the
distinct different demographics of our sample, which
mainly included middle-aged women. Despite Han and
Eskin’s meta-analysis method that provides robust results
in presence of heterogeneity [20], the results did not provide
a conclusive evidence either to validate or reject the novel
locus.
We, then, performed a conditional analysis using Twin-
sUK dataset, including rs7164338 as a covariate, to identify
potential independent secondary signals at this locus. The
results of this analysis (Supplemental Figure 3, http://link-
s.lww.com/HJH/A521) did not find any significant evidence
for an independent signal. Therefore, we looked for com-
mon variants (MAF  10% based on the European samples
included in the 1000 Genomes Project) in tight linkage
disequilibrium (r2 > 0.8) with the top SNP rs7164338 in
order to identify potential causal alleles in the coding
sequence. We identified nine SNPs (Supplemental
Table 1, http://links.lww.com/HJH/A521) of which only
one (rs10456, r2¼ 0.86) was in CIB2 coding region causing
a synonymous change (aspartic acid to aspartic acid) in
four over nine transcripts. However, the functional anno-
tation analysis using data from the ENCODE [23] project on
this polymorphism did not suggest any significant evidence
for a potential functional role (Supplemental Table 1,
http://links.lww.com/HJH/A521). Conversely, rs7164338
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significance threshold (510–8). In green is reported the lead single-nucleotide polymorphism rs7164338.
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functional annotation analysis showed that this variation is
located in an area of histone protein H3K4me1 chromatin
modification associated with transcription enhancer and
promoter sequences; altered regulatory motifs and affected
one binding site for the transcription factor neuron-restric-
tive silencer factor (NRSF) (Supplemental Table 1, http://
links.lww.com/HJH/A521). Altogether these evidences
suggest that rs7164338 may have a potential regulatory
function.
In order to explore rs7164338 theoretical functional
impact, we analysed CIB2 expression data from the
MuTHER [26] (http://www.muther.ac.uk/) based on 856
unselected twins sampled for skin, adipose tissue and LCLs.
We first focused our analysis on LCL and found that the
minor allele (C) of rs7164338 was associated with higher
expression of CIB2 (ILMN_1714489, P¼ 4.95 10–5)
(Table 4). These results were validated (P¼ 5.9 10–3)
by analyzing LCL expression levels measured in 109
Centre d’Etude du Polymorphisme Humain (CEPH) indivi-
duals by Stranger et al. [28]. Owing to both Stranger et al.
and MuTHER consortium utilized the same probe
(ILMN_1714489) to assess the expression levels in the
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FIGURE 2 Regional plot of CIB2 locus. Observed P values (log10) are plotted against base-pair position. The lead SNP (rs7164338) is represented as a purple diamond and
the linkage disequilibrium relationship (r2) with other SNPs in the region are indicated by the colour of the circles. Blue peaks represent recombination rates (HapMap 2),
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TABLE 2. Summary results for the newly identified single-nucleotide polymorphisms associated with pulse wave velocity on chr 15q25.1
SNP Chr Position Effect allele Effect allele frequency b (SE) P value
rs11639461 15 76176384 C 0.23 0.320 (0.075) 1.981005
rs2867922 15 76179024 A 0.23 0.320 (0.074) 1.751005
rs9806257 15 76182417 C 0.30 0.284 (0.066) 3.441006
rs7164338 15 76184901 C 0.25 0.359 (0.072) 4.801008
rs10456 15 76185201 A 0.24 0.330 (0.073) 9.131007
rs11072728 15 76187728 A 0.25 0.347 (0.071) 1.581007
rs11072729 15 76189056 C 0.26 0.323 (0.070) 4.921007
rs2304829 15 76190347 C 0.28 0.298 (0.069) 7.051006
rs12440984 15 76194548 C 0.24 0.336 (0.072) 6.021007
rs8032449 15 76195510 A 0.29 0.307 (0.067) 1.501006
rs11630013 15 76221978 A 0.17 0.324 (0.080) 7.561005
SE, standard error; SNP, single-nucleotide polymorphism.
Calcium and integrin-binding protein-2
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analysed tissues, we checked the presence of any genetic
variant in the probe sequence which may have affected the
efficiencyof thehybridizationand, consequently, our results.
The analysis revealed that no polymorphism was present in
the probe sequence.
Given the histological similarities between the central
arteries and the skin (both are elastic connective tissues
enriched by elastic fibres such as elastin [34]), we hypoth-
esized that the analysis of the expressions level of CIB2 in
skin would give a more comparable result with its expres-
sion in the vascular tissue. Indeed, our results showed a
stronger association (P¼ 2.35 10–9) of rs7164338 minor
allele with CIB2 expression levels in skin when compared
with the LCL results (Table 4). Finally, we used the GTEx
Portal [29] to examine the association rs7164338–CIB2
specifically in the artery aorta tissue. Despite the small
sample size included in the database for this tissue
(n¼ 72), also in this case, the analysis highlighted a highly
significant association (P¼ 4 10–4) between rs7164338
and CIB2 expression levels.
We hypothesized that the different level of expression in
the participant carrying the minor allele may be due to a
methylation change. We tested the association between
rs7164338 and the DNA methylation profile of 69 probes
mapping across the CIB2 locus. After correction for
multiple testing, rs7164338 minor allele was significantly
associated with lower methylation levels of two probes
(cg20761322, P¼ 3.63 10–20, and cg20509675,
P¼ 2.28 10–11) (Table 5).
The association between rs7164338 and cg20761322 was
validated in further 172 independent samples (analysed
with HumanMethylation27 DNA Analysis BeadChip assay)
obtaining a similar highly significant association result
(P¼ 3 10–9) (Table 5).
The association between rs7164338 and cg20761322 was
of particular interest because this probe maps 6 bp
upstream CIB2 start codon of (cg20509675 maps 3 bp
downstream the start codon) suggesting a hypothetical
regulatory effect on CIB2 expression. Therefore, using all
TwinsUK individuals (n¼ 221) with both expression and
TABLE 3. Meta-analysis results for rs7164338a
Dataset N MAF b SE P values I2 Het P
TwinsUK 1505 0.25 0.359 0.072 4.801008
AortaGen Consortium 20634 0.25 0.010 0.012 4.09101
Combined 22139 0.25 0.177 0.174 5.87105 95% 1.8310–6
Het P, heterogeneity P; MAF, minor allele frequency; SE, standard error.
ab and SE values refer to the minor allele C in both TwinsUK and AortaGen datasets.
TABLE 4. Association results for rs7164338 and calcium and integrin-binding protein-2 expression levels in lymphoblastoid cell lines (LCLs)
and skin from the Multiple Tissue Human Expression Resource (MuTHER)a
Probe b (SE) P value
ILMN_1714489 (LCL) 0.034 (0.008) 4.951005
ILMN_1714489 (Skin) 0.072 (0.012) 2.351009
CIB2, calcium and integrin-binding protein-2; SE, standard error.
ab values refer to the effect allele C.
TABLE 5. Association summary statistic for rs7164338 and the methylation probes after correction for multiple testing in the discovery
dataseta
Discovery Replication
Probe b (SE) P value b (SE) P value
cg20761322 0.899 (0.098) 3.631020 0.022 (0.004) 310–9
cg20509675 0.611 (0.091) 2.281011 NA NA
NA, not available; SE, standard error.
aIn the replication sample, only cg20761322 was available for the analysis. b values refer to the effect allele C.
TABLE 6. Summary results of the Mendelian randomization
Association
(SNP–expression)
Association
(SNP–methylation)
Association
(methylation–
expression)
Mendelian
randomization
(SNP ! methyl-
ation ! expres-
sion)
Locus SNP EA/OA Methylation probe N b (SE) P value b (SE) P value b (SE) P value b (SE) P value
CIB2 rs7164338 C/T cg20761322 221 0.4 (0.11) 4.81004 0.84 (0.12) 8.31011 0.17 (0.07) 1.21002 0.48 (0.14) 61004
CIB2, calcium and integrin-binding protein-2; EA, effect allele; OA, other allele; SE, standard error; SNP, single-nucleotide polymorphism.
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methylation information available, we tested the relation-
ship between expression and the methylation levels detect-
ing a statistically significant association (b¼0.17 0.07,
P¼ 1.2 10–2) (Table 6) between cg20761322 and LCL
CIB2 expression levels. This observation, however, cannot
distinguish between association and causation [31]. There-
fore, to formally test the causal relationship between DNA
methylation (probe cg20761322) in this region and expres-
sion of LCL CIB2, we performed a Mendelian randomiz-
ation analysis utilizing rs7164338 as the instrumental
variable [32]. Our results (based on the 221 samples
with genomic/methylation/expression data) showed that
cg20761322 may have a significant genotype-dependent
causal effect on it (P¼ 6 10–4) (Table 6).
DISCUSSION
In this article, we conducted a GWA analysis of PWV. The
overall power calculations based on our dataset showed
that we have 80% power to detect a genetic variant which
has an effect on PWV of 0.73m/s at genomewide statisti-
cal level. Indeed, based on our current knowledge on
common complex traits, this very large effect size is unlikely
to be determined by a single SNP [35].
We identified a novel variant (rs7164338) on chromo-
some 15q25.1 in the CIB2 associated with lower PWV. This
finding was supported using a whole ‘omics’ approach.
Some caution should be exercised in extending these
results to other populations and further studies are needed
to validate these results in independent cohorts matching
our study characteristics (our study was mainly composed
of females (99.2%) of European descendent). Recent stud-
ies reported a significant difference of arterial stiffness
between women and men [36] and among different ethnic
groups [37,38]. Indeed, although the minor allele effect was
in the same direction, we were not able to fully validate our
result in a dataset including nine different populations with
a nearly 50 : 50 sex ratio [10]. Nevertheless, the findings
reported here were supported by three independent ‘omics’
datasets performed with different techniques in different
centres. Moreover, highly stringent threshold values have
been applied for each analysis performed to minimize the
possibility that our results are not true-positive findings.
CIB2 is part of the CIB1-related proteins family that are
characterized by an EF-hand domain [39]. These proteins
are activated to respond to intracellular levels of calcium
(Ca2þ) that play a pivotal role in Ca2þ intracellular homeo-
stasis [39]. Moreover, numerous studies have implicated the
paralogue CIB1 (38% identical and 59% similar to CIB2 [39]),
in cardiac hypertrophy [40] and atrial fibrillation, and in
valvular heart disease [41]. In particular, CIB1 is a master
regulator of the calcineurin-nuclear factor of activated T
cells signalling pathway [40]. Of note, this pathway has
recently been implicated in vascular calcification via differ-
entiation of vascular smooth muscle cells towards an osteo-
blast-like phenotype [42]. Considering the similarity with
CIB1, it is plausible to hypothesize a functional role of CIB2
in arterial calcification via regulation of the calcineurin-
nuclear factor of activated T cells pathway.
Another likely function of CIB2, which is not mutually
exclusive, is the regulation of Ca2þ serum levels [43]. In
particular, a number of epidemiological and experimental
studies have implicated elevated level of serum Ca2þ in the
initial stages of vascular calcification [44–47].
We find that CIB2 expression is mediated through a
differentially methylated position in the promoter region.
Therefore, we hypothesize a mechanism regulated by
methylation of the CIB2 promoter region in which CIB2
may be more expressed in individuals carrying the
rs7164338 minor allele resulting, as a consequence, in a
less-accelerated vascular calcification and, ultimately, in a
lower PWV (Fig. 3).
Our group have previously shown that the association of
arterial stiffness with calcification is independent of coex-
istent atheromatous plaque [9]. The results reported in this
article validate these observations [9,13], suggesting that
arterial stiffness is the effect of arterial calcification and
regulated by common genetic influence.
In conclusion, using a multi-‘omics’ approach, we pro-
vided the first evidences that CIB2 may be responsible for
PWV variation in humans, generating the foundation for
future biological research in the calcium regulation and its
connections with vascular ageing. This study also demon-
strated new potential of a combined omics strategy in
cardiovascular research.
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